Ahgren, C., et al., 1995, Antimicrob. Agents Chemotherapy, 39, 1329-1335 The PETT Series, a New Class of Potent Nonnucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. |
Baba, M., et al., 1992, Antiviral Res, 17, 245-264 Highly potent and selective inhibition of HIV-1 replication by 6-phenylthiouracil derivatives. |
Balzarini, J. et al., 1992, Proc. Natl. Acad. Sci. U S A, 89, 4392-4396 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"-oxathiol-2",2"-dioxide)pyrimidine (TSAO) nucleoside analogues: Hightly selective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase. |
Bartlett, P.A. et al., 1989, Molecular Recognition in Chemical and Biological Problems, Special Pub., Royal Chem. Soc., 78, 182-196 Caveat: A Program to Facilitate the Structure-derived Design of Biologically Active Molecules. |
Bell, F. W., et al., 1995, J. Med. Chem., 38, 4929-4936 Penethylthiazolethiourea (PETT) Compounds, a New Class of HIV-1 Reverse Transcriptase Ihhibitors. 1. Syntheis and Basic Structure-Activity Relationship Studies of PETT Analogs. |
Blaney, J.M. and Dixon, J.S., 1993, Perspectives in Drug Discovery and Design, 1, 301 A good ligand is hard to find: Automated docking methods. |
Bohm, H. J., 1992, J. Comput. Aided. Mol. Des., 6, 593-606 LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads. |
Bohm, H.J., 1992, J. Comp. Aid. Molec. Design, 6, 61-78 The computer program LUDI: A new mehtod for the de novo design of enzyme inhibitors. |
Bohm, H. J., J. Comput. Aided. Mol. Des., 1994, 8, 243-256; 1996 The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of konwn three-dimensional structure. |
Bosworth, N., et al., 1989, Nature, 341: 167-168 Scintillation proximity assay. |
Brooks, B.R. et al., 1983, J. Comp. Chem., 4, 187-217 CHARMM: A Program for Macromolecular Energy, Minimization, and Dynamics Calculations. |
Burkert, U. and Allinger, N.L., 1982, Molecular Mechanics, ACS Monograph, 177, 59-78, American Chemical Society, D.C. Methods for the Computation of Molecular Geometry. |
Cantrell, A. S., et al., 1996, J. Med. Chem., 39, 4261-4274 Phenethylthiazolythiourea (PETT) Compounds as a New Class of HIV-1 Reverse Transcriptase Inhibitors. 2. Synthesis and Further Structure-Activity Relationship Studies of PETT Analogs. |
Connolly, M. L., 1983, Science, 221, 709-713 Solvent-Accessible Surfaces of Proteins and Nucleic Acids. |
Danel, K. et al., 1997, Acta Chemica Scandinavica, 51, 426-430 Anti-HIV Active Napthyl Analogues of HEPT and DABO. |
Danel, K. et al., 1998, J. Med. Chem., 41, 191-198 Synthesis and Anti-HIV-1 Activity of Novel 2,3-Dihydro-7H-thiazolo[3,2-.alpha.]pyrimidin-7-ones. |
Danel, K., et al., 1996, J. Med. Chem., 39, 2427-2431 Synthesis and Potent Anti-HIV-1 Activity of Novel 6-Benzyluracil Analogues of 1-[2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine. |
Das, K. et al., 1996, J. Mol. Biol., 264, 1085-1100 Crystal Structures of 8-Cl and 9-Cl TIBO Complexed with Wild-type HIV-1 RT and 8-Cl TIBO Complexed with the Tyr181Cys HIV-1 RT Drug-resistant Mutant. |
De Clercq, E., 1992, J. Acquired Immune Defic. Syndr. Res. Human. Retrovirus, 8, 119-134. |
Ding, J., 1995, et al., Nat. Struct. Biol., 2, 407-415 Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors. |
Erice, A. et al., 1993, Antimicrob. Ag. Chemother., 37, 835 Anti-Human Immunodeficiency Virus Type 1 Activity of an Anti-CD4 Immunoconjugate Containing Pokeweed Antiviral Protein. |
Goodsell, D.S. and Olson, A.J., 1990, Proteins: Struct. Funct. Genet., 8, 195-202 The Molecular Biology of Human Immunodeficiency Virus Type 1 Infection. |
Greene, W. C., 1991, New England Journal of Medicine, 324, 308-317 Automated Docking of Substrates to Proteins by Simulated Annealing. |
Hopkins, A. L. et al., 1996, J. Med. Chem., 39, 1589-1600 Complexes of HIV-1 Reverse Transcriptase with Inhibitors of the HEPT Series Reveal Conformational Changes Relevant to the Design of Potent Non-Nucleoside Inhibitors. |
Jones, T. A. et al., 1991, Acta Crystallogr. A., 47, 110-119 Improved Methods for Building Protein Models in Electron Denisty Maps and the Location of Errors in these Models. |
Kohlstaedt, L. A. et al., 1992, Science, 256, 1783-1790 Crystal Structure at 3.5 .ANG. Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor. |
Kuntz, I.D., et al., 1995, J. Mol. Biol., 1982, 161, 269-288 A Geometric Approach to Macromolecule--Ligand Interactions. |
Luty, B. A. et al., 1995, J. Comp. Chem., 16, 454-464 A Molecular Mechanics/Grid Methods for Evaluation of Ligand--Receptor Interactions. |
Mai, A. et al., 1997, J. Med. Chem., 40, 1447-1454 Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: Novel Non-Nucleoside Reverse Transcriptase Indhibitors of the S-DABO Series. |
Marshall, G.R., 1987, Ann. Ref. Pharmacol. Toxicol., 27, 193 Computer-Aided Drug Design. |
Martin, Y.C., 1992, J. Med. Chem., 35, 2145-2154 3D Database Searching in Drug Design. |
Mitsuya, H. et al., 1990, Science, 249, 1533-1544 Molecular Targets for AIDS Therapy. |
Nishibata, Y. and Itai, A., 1991, Tetrahedron, 47, 8985 Automatic Creation of Drug Candidate Structures Based on Receptor Structure. Startng Point for Artificial Lead Generation. |
Pauwels, R. et al., 1990, Nature, 343, 470-474 Potent and selective inhibitionof HIV-1 replication in vitro by a novel series of TIBO derivatives. |
Pontikis, R. et al., 1997, J. Med. Chem., 40, 1845-1854 Synthesis and Anti-HIV Activity of Novel N-1 Side Chain-Modified Analogs of 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). |
Remington's Pharmaceutical Sciences, Chapter 43, 14th Ed., Mack Publishing Col, Easton PA 18042, USA Topical Drugs, 1970. |
Ren, J. et al., 1995, Structure, 3, 915-926 The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design. |
Romero, D. L. et al., 1993, J. Med. Chem., 36, 1505-1508 Bis(heteroaryl)pipeazine (BHAP) Reverse Transcriptase Inhibitors: Structure-Activity Relationships of Novel Substituted Indole Analogues and the Identification of 1-[5-Methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3-[(1-methylethyl)amino]-pyridinyl]piperazine Monomethanseulfonate (U-90152S), a Second-Generation Clinical Candidate. |
Tanaka, H. et al., 1991, J. Med. Chem., 34, 349-357 A New Class of HIV-1-Specific 6-Substituted Acyclouridine Derivatives: Synthesis and Anti-HIV-1 Activity of 5- or 6-Substituted Analogues of 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). |
Tantillo, C. et al., 1994, J Mol Biol, 243, 369-387 Locations of Anti-AIDS Drug Binding Sites and Resistance Mutations in the Three-dimensional Structure of HIV-1 Reverse Transcriptase. |
Uckun, F. M. et al., 1998, Antimicrobial Agents and Chemotherapy, 42, 383 TXU (Anti-CD7)-Pokeweed Antiviral Protein as a Potent Inhibitor of Human Immunodeficiency Virus. |
Weiner, S.J. et al., 1984, J. Am. Chem. Soc., 106, 765-784 A New Force Field for Molecular Mechanical Simulation of Nucleic Acids and Proteins. |
Zarling, J. M. et al., 1990, Nature, 347, 92-95 Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4.sup.+ cells by monoclonal antibodies. |
Tanaka, H. et al., "Synthesis of a potential photoaffinity labeling reagent for HIV-1 reverse transcriptase," Chemical Abstracts, vol. 120, No. 17, p. 1160 (Apr. 25, 1994). |
Tronchet, J. et al., "A QSAR study confirming the heteroegneity of the HEPT derivative series regarding their interaction with HIV reverse transcriptase," Eur. J. Med. Chem. vol. 32, pp. 279-299 (1997). |